课题基金 / 基金详情

Measurement of plasma sphingosine 1-phosphate

Measurement of plasma sphingosine 1-phosphate
血浆 1-磷酸鞘氨醇的测定
批准号:
08672635
负责人:
YATOMI Yutaka
金额:
$1.41万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997

项目摘要

项目成果

YATOMI Yutaka的其他基金

相似基金

相关文献

中文摘要
翻译
尽管鞘氨醇1-磷酸(Sph-1-P)据报道参与多种细胞过程,并且这种生物活性鞘脂的生理作用已被强烈提出,但很少有研究表明在生理条件下人体样本(包括体液和细胞)中存在Sph-1-P。在这项研究中,我们确定了Sph-1-P是人类血浆和血清的正常成分。血浆和血清Sph-1-P水平为191 ([SY.+-])。[) 79和484 [](]SY.+-。[) 82pmol /ml(平均值)[][) SD,n=8)。此外,当对6名健康成人的配对血浆和血清样本进行Sph-1-P测量时,发现血清Sph-1-P/血浆Sph-1-P比值为2.65 (]SY.+-)。[) 1.26(平均值)[](SD)。在凝血过程中释放的Sph-1-P最有可能是来自血小板,因为血小板比其他血细胞更丰富地储存Sph-1-P,并在刺激时将其储存的部分Sph-1-P释放到细胞外。我们还研究了血浆中sph -1- p的相关代谢。[<@D13@>D1H] Sph在血浆中稳定且完全不被代谢,但在富血小板血浆中被迅速并入血小板并主要代谢为Sph-1- p。[<@D13@>D1H]发现血浆中Sph不变,表明血浆中不含降解Sph-1- p所需的酶。总之,血小板可以将Sph转化为Sph-1- p,并且是后者在血液中的储存场所。鉴于Sph-1-P的多种生物学作用,活化血小板释放Sph-1-P可能参与多种生理和病理生理过程,包括血栓形成、止血、动脉粥样硬化和伤口愈合。
英文摘要
Although sphingosine 1-phosphate (Sph-1-P) is reportedly involved in diverse cellular processes and the physiological roles of this bioactive sphingolipid have been strongly suggested, few studies have revealed the presence of Sph-1-P in human samples, including body fluids and cells, under physiological conditions. In this study, we identified Sph-1-P as a normal constituent of human plasma and serum. The Sph-1-P levels in plasma and serum were 191 (]SY.+-。[) 79 and 484 (]SY.+-。[) 82 pmol/ml (mean (]SY.+-。[) SD,n=8), respectively. Furthermore, when Sph-1-P was measured in paired plasma and serum samples obtained from 6 healthy adults, the serum Sph-1-P/plasma Sph-1-P ratio was found to be 2.65 (]SY.+-。[) 1.26 (mean (]SY.+-。[) SD). It is most likely that the source of discharged Sph-1-P during blood clotting is platelets, because platelets abundantly store Sph-1-P compared with other blood cells, and release part of their stored Sph-1-P extracellularly upon stimulation. We also studied Sph-1-P-related metabolism in plasma. [<@D13@>D1H] Sph was stable and not metabolized at all in plasma, but was rapidly incorporated into platelets and metabolized mainly to Sph-1-P in platelet-rich plasma. [<@D13@>D1H] Sph was found to be unchanged in plasma, revealing that plasma does not contain the enzymes needed for Sph-1-P degradation. In summary platelets can convert Sph into Sph-1-P,and are storage sites for the latter in the blood. In view of the diverse biological effects of Sph-1-P,the release of Sph-1-P from activated platelets may be involved in a variety of physiological and pathophysiological processes, including thrombosis, hemostasis, atherosclerosis and wound healing.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
Yatomi, Y., Yamamura, Y., Ruan, F., Kume, S., Ozaki, Y., and Igarashi, Y.: "N,N-Dimethylsphingosine 1-phosphate activates human platelets." FEBSLett.417. 341-344 (1997)
Yatomi, Y.、Yamamura, Y.、Ruan, F.、Kume, S.、Ozaki, Y. 和 Igarashi, Y.:“N,N-二甲基鞘氨醇 1-磷酸可激活人血小板。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yutaka Yatomi: "Sphingosine 1-phosphate,a bioactive sphimgolipid abundantly stored in platelets,is a normal constituent of human plasma and serum" Journal of Biochemistry.
Yutaka Yatomi:“1-磷酸鞘氨醇是一种大量储存在血小板中的生物活性鞘脂,是人体血浆和血清的正常成分”《生物化学杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yatomi Y: "Sphingosine 1-phosphate,a bioactive sphingolipid abundently stored in platelets,is a normal constituent of human plasma and serum" Journal of Biochemistry. 121. 969-973 (1997)
Yatomi Y:“1-磷酸鞘氨醇是一种大量储存在血小板中的生物活性鞘脂,是人体血浆和血清的正常成分”《生物化学杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yatomi Y: "Sphingosine 1-phosphate,a,bioactive sphingolipid abundantly stored in platelets,is a normal constituent of human plasma and serum" Journal of Biochemistry. 121. 969-973 (1997)
Yatomi Y:“1-磷酸鞘氨醇,一种生物活性鞘脂,大量储存在血小板中,是人体血浆和血清的正常成分”《生物化学杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
6
    Establishment of laboratory medicine of lipid mediators
    • 批准号:
      22249017
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $18.8万
    • 财政年份:
      2010
    • 负责人:
      YATOMI Yutaka
    • 依托单位:
    Analysis of platele-derived bioactive substances : establishment of platelet biology and its application into laboratory medicine
    • 批准号:
      18209020
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $20.05万
    • 财政年份:
      2006
    • 负责人:
      YATOMI Yutaka
    • 依托单位:
    The significance of lysophosphatidic acid in vascular biology and application of its measurement into laboratory medicine
    • 批准号:
      16390162
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $3.84万
    • 财政年份:
      2004
    • 负责人:
      YATOMI Yutaka
    • 依托单位:
    The significance of sphingosine 1-phosphate in vascular biology and its application to laboratory
    国内基金
    海外基金
    Sphingosine通路在肺癌发生的作用机制
    • 批准号:
      82172565
    • 项目类别:
      面上项目
    • 资助金额:
      55万元
    • 批准年份:
      2021
    • 负责人:
      邓炯
    • 依托单位:
    鞘氨醇衍生物靶向Cer-Sph-S1P调控乳腺癌他莫昔芬耐药及免疫抑制
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2019
    • 负责人:
      孟琼
    • 依托单位:
    磷脂转运蛋白通过磷酸鞘氨醇1影响高密度脂蛋白抗动脉粥样硬化功能的分子机制
    • 批准号:
      81070247
    • 项目类别:
      面上项目
    • 资助金额:
      33.0万元
    • 批准年份:
      2010
    • 负责人:
      秦树存
    • 依托单位:
    S1P介导骨髓间充质干细胞参与肝纤维化的机制研究
    • 批准号:
      30971348
    • 项目类别:
      面上项目
    • 资助金额:
      31.0万元
    • 批准年份:
      2009
    • 负责人:
      李丽英
    • 依托单位: